Takeda Pharmaceutical (Germany) Performance
| TKDA Stock | EUR 13.60 0.10 0.74% |
Takeda Pharmaceutical has a performance score of 7 on a scale of 0 to 100. The entity has a beta of 0.3, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Takeda Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Takeda Pharmaceutical is expected to be smaller as well. Takeda Pharmaceutical right now has a risk of 1.24%. Please validate Takeda Pharmaceutical jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to decide if Takeda Pharmaceutical will be following its existing price patterns.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain fundamental indicators, Takeda Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
| Begin Period Cash Flow | 966.2 B | |
| Total Cashflows From Investing Activities | -198.1 B |
Takeda |
Takeda Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 1,270 in Takeda Pharmaceutical on December 2, 2024 and sell it today you would earn a total of 90.00 from holding Takeda Pharmaceutical or generate 7.09% return on investment over 90 days. Takeda Pharmaceutical is generating 0.1199% of daily returns assuming 1.2423% volatility of returns over the 90 days investment horizon. Simply put, 11% of all stocks have less volatile historical return distribution than Takeda Pharmaceutical, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Takeda Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Takeda Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Takeda Pharmaceutical, and traders can use it to determine the average amount a Takeda Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0965
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | TKDA | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.24 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Takeda Pharmaceutical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Takeda Pharmaceutical by adding it to a well-diversified portfolio.
Takeda Pharmaceutical Fundamentals Growth
Takeda Stock prices reflect investors' perceptions of the future prospects and financial health of Takeda Pharmaceutical, and Takeda Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Takeda Stock performance.
| Return On Equity | 0.0477 | |||
| Return On Asset | 0.0247 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 71.66 B | |||
| Shares Outstanding | 3.12 B | |||
| Price To Earning | 29.55 X | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 3.57 T | |||
| EBITDA | 1.05 T | |||
| Cash And Equivalents | 1000 B | |||
| Cash Per Share | 320.73 X | |||
| Total Debt | 4.14 T | |||
| Debt To Equity | 0.99 % | |||
| Book Value Per Share | 1,986 X | |||
| Cash Flow From Operations | 1.12 T | |||
| Earnings Per Share | 0.61 X | |||
| Total Asset | 13.18 T | |||
About Takeda Pharmaceutical Performance
By analyzing Takeda Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Takeda Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Takeda Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Takeda Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. TAKEDA PHARM operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.Things to note about Takeda Pharmaceutical performance evaluation
Checking the ongoing alerts about Takeda Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Takeda Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Takeda Pharmaceutical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Takeda Pharmaceutical's stock performance include:- Analyzing Takeda Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Takeda Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Takeda Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Takeda Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Takeda Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Takeda Pharmaceutical's stock. These opinions can provide insight into Takeda Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Takeda Stock analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |